SEC Form 4 · accession 0001209191-15-083959
OMEGA PROTEIN CORP · OME
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrew Johannesen
Officer — Exec VP and CFO
Period of report
Dec 4, 2015
Accepted (ET)
Dec 8, 2015 · 4:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001053650
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2,F3 | Dec 4, 2015 | S | 4,128 | $23.10 | D | 83,945 | D | |
| Common StockF1,F2,F4 | Dec 4, 2015 | S | 1,170 | $23.84 | D | 82,775 | D | |
| Common StockF5 | Dec 4, 2015 | F | 10,543 | $23.32 | D | 72,232 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Restricted Stock Award vested on December 4, 2015 and shares sold automatically pursuant to Trading Plan (SEC Rule 10b5-1) in order to satisfy additional tax liability.
- F2Full information regarding the number of shares purchased or sold at each separate price will be provided by the filer to the Commission staff, the issuer, or a security holder of the issuer upon request.
- F3Value represents transactions with a weighted average sales price ranging from $22.65 to $23.62.
- F4Value represents transactions with a weighted average sales price ranging from $23.73 to $24.05.
- F5Payment of tax liability by withholding Common Stock incident to vesting of Common Stock award issued in accordance with Rule 16b-3.